You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. At-Home Minimally Invasive Tacrolimus Plasma Level Monitoring Device

    SBC: REAL-TIME ANALYZERS INC            Topic: A18145

    The overall goal of this proposed project (through Phase III) is to develop the Tacrolimus At-home Saliva Test (TAST) to measure tacrolimus at ng/mL levels in oral fluid (saliva) at-home in 15-20 minutes.  The TAST will replace the painful blood tests currently performed at hospital and clinics that military patients, who have limb, facial and organ transplants, must undergo to avoid transplant r ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  2. Dry Electrode Flight helmet Integrated Eeg System (DEFIES), Phase II

    SBC: QUANTUM APPLIED SCIENCE & RESEARCH INC            Topic: DHA222001

    The National Commission on Military Aviation Safety determined that between 2013 and 2020, 224 lives, and 186 aircraft were lost due to military aviation mishaps amounting to losses of $11.6 billion. It is well documented that there is a negative impact on mission performance and an increased risk of accidents associated with sleep deprivation, extended time on intense attention demanding tasks, p ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  3. Determining the Need and Compatibility of a Metalloprotease Inhibiter with Broad Spectrum Envenomation Treatment

    SBC: OPHIREX, INC            Topic: DHA18002

    SEQUENTIAL SBIR PHASE II TECHNICAL OBJECTIVES AND APPROACH All activities of this proposed Sequential SBIR II are directed toward determining the incremental benefit of adding a metalloprotease inhibitor to varespladib for improving recovery and return to duty time following snakebite envenoming. The work will also advance the TRL of the metalloprotease inhibitor in order to support a SBIR III eff ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  4. Graphical Methods for Discovering Structure and Context in Large Datasets

    SBC: MAYACHITRA, INC.            Topic: NGA203005

    In this proposed Phase II effort we will implement a software framework that will reduce the time required to annotate large image/video datasets by a factor of 100x while also reducing the data necessary to train state of the art computer vision models by up to 80%. Our strategy combines several elements and ideas. First, we have developed a sub-tile based a priori theory of how and why CNNs can ...

    SBIR Phase II 2023 Department of DefenseNational Geospatial-Intelligence Agency
  5. HIGH-SPEED ELECTRO-OPTIC SHUTTER

    SBC: TP ENGINEERING SERVICES, LLC            Topic: NGA212001

    In Phase I we developed and demonstrated a bi-directional, monolithic, High-Speed, Electro-optic shutter for Range Gated Imaging. While meeting the majority of the key performance parameters for Range-Gated Imaging at high Pulse Repetition Frequency, improvements can be achieved in transmission, contrast and reliability. The Phase Ii activity begins with a upgraded Electro-optic Shutter incorpora ...

    SBIR Phase II 2023 Department of DefenseNational Geospatial-Intelligence Agency
  6. Rx-Shooter Wearable Wound Infection Treatment Device

    SBC: CRITICAL INNOVATIONS LLC            Topic: DHA213009

    The Defense Health Agency seeks to develop a novel wearable wound infection treatment delivery device capable of delivering treatment for the prevention of infection in a prolonged care setting. Critical Innovations, NDA Partners, IOTAI, and consultants Loren Miller, MD, MPH, Gary Fong, PharmD, BCPS, BCIDP, Captain David Tanen, MD, FAAEM, FACMT (USN, Ret.), and former Commander Denise Whitfield, M ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  7. Donaldson Decompression Needle for automated diagnosis and treatment of tension pneumothorax

    SBC: CRITICAL INNOVATIONS LLC            Topic: DHA191007

    The purpose of this SBIR topic is to develop a device for automating needle decompression to more effectively manage tension pneumothorax on the battlefield.

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  8. Portable Oculomotor and Multi-sensing Assessment System (POMAS)

    SBC: VISTENDO INC            Topic: DHA192003

    The overall objective of the Phase II program is to develop and commercialize a portable, reliable, easy-to-use medical device called POMAS (Portable Oculomotor Multi-sensing Assessment System) (Figure 1) with associated software in order to enable non-invasive, fast, accurate and objective full spectrum oculomotor testing combined with 2 involuntary ANS (Autonomic Nervous System) measurements for ...

    SBIR Phase II 2023 Department of DefenseDefense Health Agency
  9. Ceramic membrane based portable oxygen generator (CEMPOG)

    SBC: CHROMOLOGIC LLC            Topic: DHA211009

    In order to address this urgent need, ChromoLogic LLC (CL) proposes to develop a ceramic membrane based portable oxygen generator (CEMPOG) to support the supply of medical grade oxygen for forward surgical teams. Unlike the regular membrane separation process, CEMPOG adopts mixed ionic–electronic conducting (MIEC) ceramic membrane to generate ultrapure O2 from ambient air, in which the oxygen mo ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
  10. Radioprotection by JP4-039-MLV nanoparticle drugs

    SBC: CHROMOLOGIC LLC            Topic: DHA211007

    In order to meet the DoD’s need for a prophylactic medical countermeasure to reduce the risk of acute radiation syndrome (ARS) when taken before exposure to ionizing radiation, ChromoLogic proposes to develop multilamellar vesicle-encapsulation JP4-039 (JP4-039-MLV) as a radioprotector of ionizing radiation (IR)-induced health risks. DoD personnel, such as members of the Joint Forces, would self ...

    SBIR Phase II 2022 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government